Co., Ltd. ("Biocytogen", HKEX: 02315), a global biotechnology company focused on the discovery of novel antibody-based therapeutics, today announced a TCR-mimic antibody evaluation and potential ...
People with cancer may encounter checkpoint inhibitors as a treatment option but may not know where to start. This article ...
However, there were two differences — researchers used patients’ tumor cells to create a personalized vaccine ... turned into ...